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Abstract The prevalence of Alzheimer’s disease (AD) and other forms of dementia is increasing
with the aging population, both in the United States and around the globe. The inabil-
ity to cure these conditions results in prolonged and expensive medical care. Early
detection is critical to potentially postpone symptoms and to prepare both health-
care providers and families for subjects’ future needs. Current detection methods are
typically costly or unreliable, and much stands to benefit from improved recognition
of early AD markers. Electronic patient records provide the potential for computa-
tional analysis and prediction of complex diseases like AD. Whereas prior work on
this problem has focused on structured data (e.g. test results) alone, this study inte-
grates structured and unstructured (e.g. clinical notes) from the Alzheimer’s Disease
Neuroimaging Initiative (ADNI)* for classification of subjects’ dementia status. Pre-
diction based on unstructured data alone performs with similar accuracy compared to
structured data, and integration of the two provides performance improvements over
either in isolation. In addition, we provide insights into which structured features were
more useful for classification of AD, supporting previously observed trends, while also
highlighting the potential for computational methods to discover new early markers.
Keywords electronic medical data; Alzheimer’s Disease Neuroimaging Initiative (ADNI); struc-
tured and unstructured data; integrating heterogeneous data
1. Introduction
Dementia is an increasing problem for the US and global aging population. Approximately
35 million people worldwide suffer from some form of dementia, and this number is expected
to double by the year 2030 [13]. It is the 6th leading cause of death in the US [1]. Alzheimer’s
Disease in particular has no cure, and treatments are limited, making management of symp-
toms the main focus of clinical care. Accordingly, there is a high medical cost associated
with dementia care, expected to total 214 billion dollars in the US for the year 2014 [1].
*Data used in preparation of this article were obtained from the Alzheimer’s Disease Neuroimaging Initiative
(ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the
design and implementation of ADNI and/or provided data but did not participate in analysis or writing
of this report. (Per data use agreement, information about the ADNI data are included verbatim from the
ADNI project in Section 3.1 and Acknowledgments.) A complete listing of ADNI investigators can be found
at: http://adni.loni.usc.edu/wp-content/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf.
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Early detection is critical for potential management of symptoms, and for allowing families
to adjust and adequately plan for the future. Despite this importance, current detection
methods are costly, invasive, or unreliable. Consequently, most patients are not diagnosed
until their symptoms have already progressed. Improved understanding and recognition of
early warning signs of dementia would greatly benefit the detection and management of the
disease, as well as facilitate appropriate allocation of resources for healthcare organizations’
provision of care.
With the advent of electronic health records (EHRs) comes the potential for large-scale
computational analysis of patients’ clinical data to understand or discover warning signs
of the progression of medical conditions. In this context, the data can be considered either
structured or unstructured. Examples of structured data include patient demographics, such
as age, sex, or ethnic background, as well as test results collected during their visits, such
as brain volume measurements or routine blood tests. When a patient is already suspected
of having dementia, there is a battery of biological and cognitive tests that can be applied
by a clinical professional. However, cognitive tests focus on already observable symptoms. It
would be useful to identify early signs that can point towards an individual being at-risk of
developing dementia. Intelligent decision-support models that could detect such cases would
be very helpful for healthcare providers. Moreover, while certain clinical tests are used in
daily operations for dementia diagnosis, other early biophysical or cognitive-social markers
may be undiscovered. Here we explore a range of features in a machine learning context to
identify useful features for classifying patients’ dementia status.
We are also are interested in understanding the roles of different types of medical data in a
prediction process, especially since prior work has focused primarily on structured informa-
tion. Accordingly, we explore what potential role unstructured data can play in data mining
for dementia prediction. Unstructured data refers to text entries, such as patient histories,
impressions, visit summaries, discharge summaries, or other broader or narrower categories.
Written, clinical text presents a potentially rich source of information that embeds useful
clinical knowledge from the professionals who wrote them. Insights mined from natural lan-
guage data may be quite straightforwardly interpretable by humans, and written texts may
provide opportunities to capture distinct types of information (e.g. as related to behavioral
wellness or social lifestyle patterns), compared to structured entries. Additionally, some form
of text is present in nearly all patient records, whereas many of the relevant structured data
may be absent if the patient has not already been identified as being at-risk for a given
condition. Thus, we examine ways in which unstructured data may supplement a diagnostic
model based on structured data. Specifically, we integrate models based on each data type
to improve performance over either in isolation.
A computational model based on either or both these data types could be used in an
automated screening system to identify and flag potentially problematic patients for further
assessment by clinicians, making operations more efficient. Additionally, identification of
useful features from classification experiments may improve understanding of important
markers in early dementia and Alzheimer’s Disease detection.
2. Related Work
The potential of electronic medical records for data mining has been recognized for some
time. Importantly, deducing data-driven patterns based on structured data has been the
basic approach in the prediction of dementia. Biomarkers from cerebrospinal fluid (CSF), as
well as brain volume measurements from magnetic Resonance Imaging (MRI) and Positron
Emission Tomography (PET), have been useful in predicting conversion from Mild Cognitive
Impairment (MCI) to Alzheimer’s Disease (AD) within the ADNI dataset [15]. Cognitive
tests may be useful to this end as well, in the absence of other biophysical tests [7] or
in combination with them [4]. However, such tests are not typically applied until after
symptoms of MCI or dementia have already been observed.
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Although the use of structured data has been successful in dementia and AD prediction,
unstructured text data may provide new or additional benefits for modeling purposes. Nat-
ural language processing (NLP) and statistical text mining (STM) techniques that have
been applied to medical texts in the past have focused on extracting known disease markers
obtained from medical knowledge sources for machine learning purposes. Examples include
mapping terms to a medical ontology to predict post-operative complications [10], and using
tools like MedLEE or SymText to extract and codify terms for identifying cases of colorectal
cancer [17], suspicious mammogram findings [9], adverse events related to central venous
catheters [12], and bacterial pneumonia from chest X-rays [5]. For the scope of this paper,
we examine the utility of bag-of-words modeling for capturing important linguistic units in




The dataset used here was obtained from the Alzheimer’s Disease Neuroimaging Initiative
(ADNI) database (adni.loni.usc.edu). The ADNI was launched in 2003 by the National
Institute on Aging (NIA), the National Institute of Biomedical Imaging and Bioengineering
(NIBIB), the Food and Drug Administration (FDA), private pharmaceutical companies and
non-profit organizations, as a $60 million, 5-year public-private partnership. The primary
goal of ADNI has been to test whether serial magnetic resonance imaging (MRI), positron
emission tomography (PET), other biological markers, and clinical and neuropsychological
assessment can be combined to measure the progression of mild cognitive impairment (MCI)
and early Alzheimer’s disease (AD). Determination of sensitive and specific markers of very
early AD progression is intended to aid researchers and clinicians to develop new treatments
and monitor their effectiveness, as well as lessen the time and cost of clinical trials. The
methods used in this paper represent a secondary use of the data for a purpose that is in
line with general goal of identifying dementia markers.
The Principal Investigator of this initiative is Michael W. Weiner, MD, VA Medical
Center and University of California San Francisco. ADNI is the result of efforts of many
co-investigators from a broad range of academic institutions and private corporations, and
subjects have been recruited from over 50 sites across the U.S. and Canada. The initial goal
of ADNI was to recruit 800 subjects but ADNI has been followed by ADNI-GO and ADNI-2.
To date these three protocols have recruited over 1500 adults, ages 55 to 90, to participate
in the research, consisting of cognitively normal older individuals, people with early or late
MCI, and people with early AD. The follow up duration of each group is specified in the
protocols for ADNI-1, ADNI-2 and ADNI-GO. Subjects originally recruited for ADNI-1
and ADNI-GO had the option to be followed in ADNI-2. For up-to-date information, see
www.adni-info.org.
3.2. Dataset Preparation and Processing
Data from the ADNI are split across multiple files, each containing different related clinical
and biomarker data. The structured data used here are obtained from a subset of the
available files in the adnimerge package, listed and described in Table 1. Each of the over
11,000 entries contained in these files represents one visit for one subject, with many subjects
having multiple visits. We aggregate entries by subject ID such that all data fields for a
given subject are contained in one vector, resulting in a collection of 1,736 subject vectors
each containing 22 structured data fields. Each data field of a given subject’s vector was
equal to the mean of the available values for that field over all of the subject’s visits. While
none of the files listed above contain any text notes, a number of other ADNI data files do
contain an optional text notes field. The list of subject IDs is used to extract text notes from
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Table 1. ADNI files used to obtain structured and unstructured data.
File Description Data type
arm Diagnosis at screening Structured
baimrinmrc Brain volume atrophy Structured
cdr Clinical Dementia Rating (CDR) scores Structured
upennbiomk5 Cerebrospinal fluid (CSF) biomarkers Structured
upennbiomk6 Cerebrospinal fluid (CSF) biomarkers Structured
upennplasma Plasma biomarkers Structured
ucberkeleyav45 PET scan with florbetapir Structured
BLLOG Baseline symptoms log Unstructured
BLCHANGE Changes since baseline visit Unstructured
RECMHIST Recent medical history Unstructured
RECADV Recent adverse events / hospitalizations Unstructured
four other files (see Table 1), which were selected both because they contained substantial
amounts of text entries and because their content seemed potentially useful for this study.
The notes from all visits for a given subject are concatenated and treated as one document
for that subject.
Mild Cognitive Impairment (MCI) is a diagnostic category regarded as a precursor to
Alzheimer’s Disease (AD). The original ADNI dataset encodes three different fine-grained
levels of MCI: Early MCI (EMCI), MCI, and Late MCI (LMCI); these were all combined into
one class label MCI to mitigate data sparseness and class imbalance issues. Additionally,
another encoding category used in the ADNI dataset is Significant Memory Complaint
(SMC). As SMC is generally thought distinct from MCI and AD, it was grouped with
cognitively normal subjects under the class label NL. The group of Alzheimer’s subjects
were left as-is, with the class label AD. Each subject was assigned a class label from this
3-class scheme based on their most recent diagnostic state, as some had changed over the
course of the ADNI collection period. As seen in in Figure 1, this labeling scheme results in
a 50% majority for the MCI class, which we consider as a baseline for comparison.
3.2.1. Handling Missing Values In general, visit entries in the ADNI dataset contain
many missing values for data fields, since not all tests are administered during every visit.
These missing values present a problem for the classification experiments we wish to perform.
Before subject aggregation, a total of 3,329 visit entries have missing values for all tests; we
exclude these in our dataset. Figure 2 shows a histogram of the fraction of the 22 structured
data fields that were missing for the remaining 8,036 visit entries (across the 1,736 subjects).
As expected, most visits are missing most available tests. To deal with this, missing values
are replaced by imputation using Amelia II [8], a package in the R programming language.
The missing values are obtained by calculating log likelihood and using the EMB algorithm
which combines the EM algorithm with bootstrapping on a subset of observed values. Amelia
II performs multiple imputations, which reduces bias and increases efficiency of the missing
data. A set of five different imputed datasets is generated, the mean of which is used to
create one dataset without missing values. As for the unstructured data, only one of the
subjects had an empty text field, which was replaced with a special empty token.
3.2.2. Text Processing and Normalization Text pre-processing included lowercasing,
punctuation removal, and stop-listing of frequent tokens such as grammatical function words
(e.g. the). Text normalization procedures were also performed to deal with variation in lin-
guistic and orthographical representations of numbers, dates, ages, abbreviations, multiword
expressions, and range expressions. In particular, dates and ages were represented in many
different forms, which were dealt with by matching and tagging with a uniform replacement
string. For example, the strings 70-year old, 70 yo, 70 years-old, and 70 y/o, etc. would
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Figure 1. Class distribution in







Note. Alzheimer’s Disease (AD),
Mild Cognitive Impairment (MCI),
Normal (NL)
Figure 2. Fraction of structured data fields containing
missing values, per visit (n= 8,036) over all subjects.



















all be replaced with the tag AGE 70. This helps with the problem of different representa-
tions of the same semantic unit not being recognized in the model, and can also allow for
generalizations such as AGE senior to be explored. The techniques applied here appear to
cover the vast majority of ambiguities and variations present in the data. Additionally, the
most frequent lexical content bigrams and trigrams (i.e. after stop-listing) in the dataset
were extracted and treated as multiword expressions (MWEs) to be replaced as unigrams
in the texts by concatenating the words with underscores (e.g. alzheimers disease became
alzheimers disease, depressed mood became depressed mood, etc.). The list was inspected
to remove any potential errors. This latter text preprocessing step was done because of
the expected high number of MWE expressions in a domain such as medicine, and to help
disambiguate meaning and aid interpretation of useful text features.
4. Predictive Modeling Approach
We report on classification models trained on features of the structured and unstructured
data in isolation, and additionally provide an integration technique for the two models. In
all cases, the goal is to predict a subject’s diagnostic state, according to the label assigned
in Section 3.2, using features of their structured or unstructured data. All experiments
make use of 10-fold cross-validation with a logistic regression classifier using L1 penalty,
implemented in Python using the scikit-learn machine learning library [11].
4.1. Structured Features
The structured data fields for each subject already contain numerical values that can be
used as features without further processing. In addition to the whole collection of structured
data features, we also experiment with a subset which excludes all three cognitive tests:
Alzheimer’s Disease Assessment Scale (ADAS), Clinical Dementia Rating (CDR) memory
score, and the Mini Mental State Exam (MMSE). The reason for this is that while cognitive
tests are powerful tools for diagnosing dementia and Alzheimer’s disease, they typically
focus on observable dementia symptoms rather than early detection. It is thus interesting
to examine their impact on classification, which we do by performing one experiment using
only non-cognitive structured features, and another using all of the structured features.
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4.2. Unstructured Features
We construct a standard bag-of-words model on the unstructured dataset and use the word
tokens as features for classification. As described earlier in Section 3.2.2, frequent bigrams
and trigrams content word sequences were treated as individual tokens in the texts to
preserve meaning of common multiword expressions, therefore this is not just a plain unigram
model. The features are treated as boolean values indicating the presence or absence of the
token in the texts for each subject.
4.3. Integration of Models
We also investigate classification performance when integrating the structured and unstruc-
tured models. For each subject, a logistic regression model will compute posterior probabili-
ties for each of the three class labels (diagnostic states) and select the most likely candidate.
If we assume that the posterior probabilities from each of two models are independent, then
Equation 1, below, can be leveraged to make a final decision in an integrated model.
p(Ck |Xs,Xu) ∝ p(Xs,Xu |Ck) p(Ck)
∝ p(Xs |Ck) p(Xu |Ck) p(Ck)
∝ p(Ck |Xs) p(Ck |Xu)
p(Ck)
(1)
Here, Xs and Xu represent the input feature vectors for the structured and unstructured
models, respectively, and Ck represents a class label (with p(Ck) being the prior probability
of the class within the dataset). As in the original models, the class label with the highest
probability is selected as the output. As with the structured features in this experiment, we
train two integrated models: one including cognitive features and one excluding them.
5. Results and Discussion
Performance metrics for each experiment are shown in Table 2, averaged over all folds.
As shown earlier in Figure 1, the majority class baseline is 50%, represented by the MCI
class. All models clearly perform well above this baseline. As expected, the inclusion of the
features obtained from cognitive tests markedly improved classification performance for the
structured models. Importantly, the unstructured features alone perform almost as well as
the structured, when cognitive features are included. In many cases, the latter may not
be available and, thus, relying on their inclusion could cause brittleness when translating
models into clinical practice. As expected, the probabilistic integration of structured and
unstructured models produced additional performance gains over each of the two feature
groups in isolation. As before, the inclusion of the cognitive markers results in greater
performance in integration, although it is a much smaller gain in this case.
In all three cases, the AD class achieved the lowest precision and recall, possibly due to the
small class size. One potential source of confusion may be the decision to combine the three
more fine-grained subcategories (EMCI, MCI, and LMCI) into one coarser-grained class
label. Thus, it is possible that EMCI and LMCI, which represent the respective peripheries
of the MCI continuum, could tend to be confused with NL and AD, respectively; this will
be examined in future work.
5.1. Structured Feature Analysis
Logistic regression is a linear classification algorithm whose decision function consists of
coefficients on each feature input, and whose output corresponds to a class. The magnitude
of a coefficient corresponds to how much influence its feature has on the overall decision,
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Table 2. Classification results using structured and unstructured features.
Class NL Class MCI Class AD
Model Accuracy Prec. Recall Prec. Recall Prec. Recall
Structured (− cognitive) 65% .67 .59 .63 .73 .69 .54
Structured (+ cognitive) 78% .83 .82 .76 .81 .75 .64
Unstructured 75% .77 .76 .78 .80 .65 .63
Integrated (− cognitive) 79% .80 .81 .80 .79 .75 .74
Integrated (+ cognitive) 82% .87 .84 .82 .84 .78 .77
Note. Accuracy is over all classes; precision and recall are reported for each of the three classes.
Table 3. Useful structured features for
Alzheimer’s Disease (AD) (coefficients signifi-
cantly non-zero).
Feature Source
CDMemory Cognitive test ***
MMSE Cognitive test ***
VBSI Boundary shift integral ***
ADAS13 Cognitive test **
Tau Cerebrospinal fluid *
Note. *** p < 0.001; ** p < 0.01; * p < 0.05
Table 4. Useful non-cognitive structured fea-




VentVol Boundary shift integral
PTau Cerebrospinal fluid
BrainVol Boundary shift integral
IPCA Magnetic resonance imaging
Note. p < 0.001 in all cases
and the sign indicates which class a higher value of the feature favors. In this section we
inspect these coefficients to gain insights into which features are more influential in deciding
a subject’s diagnostic state. We are dealing with a multi-class problem: AD vs. MCI vs. NL,
but given our primary interest in understanding indicators of Alzheimer’s Disease (AD), we
focus on the features and coefficients of the AD class alone.1.
The L1 norm penalty imposed in the algorithm aids in feature analysis by forcing many
coefficients to zero, indicating that the corresponding features are not used in the decision.
Structured features whose coefficients were significantly different than zero (p < 0.05) are
shown in Table 3 in descending order of significance. As expected, all three of the cognitive
markers - Clinical Dementia Rating memory score (CDMemory), Mini Mental State Exam
(MMSE), and Alzheimer’s Disease Assessment Scale (ADAS13) - played a significant role
in discriminating between subjects who had or did not have Alzheimer’s Disease (AD).
The Tau biomarker was also significant, verifying results in the literature [16]. As discussed
earlier, it would be beneficial to accurately identify at-risk patients who are in need of
receiving cognitive tests, therefore we perform the same feature analysis again, excluding
the cognitive markers (see Table 4), which resulted in an interesting list of other useful
structured features. Again, Tau is among the most significant, along with it’s counterpart
PTau (phospho-tau), which has been linked to neurodegenerative diseases like AD [6].
6. Conclusions
In this paper we aimed to explore both structured and unstructured data of subject records
collected as part of the Alzheimer’s Disease Neuroimaging Initiative (ADNI), using machine
learning approaches. We experimented with each data type to classify a condensed version of
subjects’ diagnoses as either normal (NL), mild cognitive impairment (MCI), or Alzheimer’s
disease (AD). A system like this would be useful as an intelligent early screening system
1 We provide analysis for structured features, but not for unstructured. The latter would be more interesting
in future work with more sophisticated modeling of the text data.
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for identifying subjects who may need more attention for dementia testing. The accuracy
of our models were well above the majority class baseline held by the MCI subjects, with
mostly comparable results for precision and recall. Arguably, high recall (e.g. in the case
of AD, the fraction of subjects with AD who were correctly classified as such) is of more
importance due to the higher cost of type II errors in this diagnostic context; future work
may involve optimizing the modeling for achieving higher recall. Integrated models based on
probabilistic output of the structured and unstructured models markedly improved classifi-
cation performance over either feature group in isolation. This is important due to the fact
that many of the tests from the structured data will not be present for patients until their
dementia symptoms have progressed, but nearly everyone will have text notes in their medi-
cal record. These texts may also allow us to capture or discover other forms of markers (e.g.
as related to a patient’s behavioral health or social-psychological experiences). In addition
to the integration, analyzing the structured features that played a greater role in classifica-
tion revealed useful features that had been identified in the past, as well as highlighted the
potential of new discovery through computational methods.
Ultimately, we hope to use topic modeling [3] to infer more complex linguistic relation-
ships in the unstructured data. Initial topic modeling experiments on the ADNI texts did
not produce viable results. We relate this in part due to the heterogeneity of language usage
enforced by the specific goals and screening processes of this dataset’s collection experi-
ments. In the future, we plan to explore general electronic health records (EHRs) with the
expectation that the full scope of typical medical visits will prove more fruitful for topic
modeling.
Additionally, we would like to explore a more sophisticated way of combining the struc-
tured and unstructured models to improve predictive power. It is possible that one may be
more suited than the other under particular circumstances, and a model that more effec-
tively combines both could be useful. To achieve this, we will explore both the boosting
technique [2], which combines multiple base classifiers to achieve better overall prediction
accuracy, as well as a recent mathematical optimization algorithm that evaluates and ranks
multiple alternatives in a group decision-making process [14].
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